CHNA
CHNA
Loncar China BioPharma ETF
$13.53 ▼ -0.07% (-0.01)
No price data available
Asset Under Management $9.97M
Inception Date Aug 15, 2018
Expense Ratio 0.79%
52w High $22.89
52w Low $9.77
Volume 9
Avg Volume 534
Asset Class Equity
About Loncar China BioPharma ETF
The Advisor attempts to invest all, or substantially all, of its assets in the component securities and depositary receipts that make up the index. The index seeks to track the performance of a modified equal-weighted portfolio of companies directly involved in the growth of China's pharmaceutical and biotech related industries.
No price data available
Asset Under Management $9.97M
Inception Date Aug 15, 2018
Expense Ratio 0.79%
52w High $22.89
52w Low $9.77
Volume 9
Avg Volume 534
Asset Class Equity
About Loncar China BioPharma ETF
The Advisor attempts to invest all, or substantially all, of its assets in the component securities and depositary receipts that make up the index. The index seeks to track the performance of a modified equal-weighted portfolio of companies directly involved in the growth of China's pharmaceutical and biotech related industries.
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
Other
87.50%
United States
China
Hong KongSECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
Other
87.50% United States China Hong Kong
